ENOX Opportunity MorNuCo's ENOX protein platform offers diagnostic and therapeutic potential for aging-related diseases, including cancer, presenting a clear pathway for licensing, co development, or collaboration on early detection and preventive treatment programs.

CRO Collaboration With a lean team, MorNuCo could accelerate R&D through outsourced preclinical studies, biomarker development, and assay services by partnering with CROs and academic partners.

Digital Enablement Their online presence and data infrastructure use WordPress and MySQL along with cloud services; opportunities exist to provide secure cloud hosting, regulatory compliant data management, and analytics to support research and outreach.

Funding Pathways MorNuCo presents opportunities for non dilutive and equity funding through grant programs and strategic investors to advance early stage development and scale collaborations.

Regional Advantage Located in Lafayette, Indiana, there is potential to partner with regional universities, biotech incubators, and local manufacturers to access talent, facilities, and co development opportunities.